Posts

UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21

Sweden gets into the Article 3 SPC referral game in AstraZeneca dapagliflozin case

Keeping up with Belgian patent litigation: Year case law review 2020

BREAKING: Court of Appeal frames Article 3(a) test as one of "claim requirement", but still upholds Truvada SPC invalidity

UCL IBIL Event: Boris v Corbyn v Trump - putting a price on patents, medicine and innovation

The novelty of “on sale inventions” under a confidentiality agreement with regards to an “on sale” invention: the US Supreme Court rules